Pharmaco - Press Releases

Date	Title	Company
14-Jan-2021	Registration Opens for SMi’s 21st Annual Pain Therapeutics Virtual Conference	SMi Group
14-Jan-2021	WIDEBLUE CONTRIBUTES TO GROUND BREAKING MRI SCANNER PROJECT	Wideblue
14-Jan-2021	Sensyne Health launches MagnifEye smartphone application to automate the reading and Big Data analysis of lateral flow tests using deep learning AI	Sensyne Health
14-Jan-2021	BRAIN AG publishes its Annual Report for the Financial Year 2019/20	B.R.A.I.N. Biotechnology Research And Information Network AG
13-Jan-2021	Drägerwerk AG & Co. KGaA: preliminary results for 2020, dividend and guidance for 2021	Drägerwerk AG & Co. KGaA
13-Jan-2021	Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty	Zur Rose Group AG
13-Jan-2021	RheinCell Therapeutics Achieves Milestone GMP Certification to Manufacture Cord Blood-Derived iPSCs for Safe and Compliant Cell Therapies	RheinCell Therapeutics
13-Jan-2021	LIQUID BIOPSY: ONE-STOP-SHOP FOR IDENTIFYING CIRCULATING TUMOR CELLS USING PCR OR IMMUNOSTAINING	OncoLab Diagnostics GmbH
13-Jan-2021	ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe	ViiV Healthcare
13-Jan-2021	Taiho and Astex Extend Strategic Oncology Collaboration with MSD Granting Exclusive License to SHP2 Program	Taiho Pharmaceutical Co, Ltd
13-Jan-2021	Ed McCaffrey and CBD Global Sciences Sign a Two-Year Endorsement Agreement with Aethics(TM), CBDN's Sports Wellness CBD Infused Brand	CBD Global Sciences, Inc.
13-Jan-2021	B.R.A.I.N. Biotechnology Research And Information Network AG: Roquette and BRAIN Group agree on production scale-up for protein sweetener	B.R.A.I.N. Biotechnology Research And Information Network AG
13-Jan-2021	Formycon's Scientific Collaboration Partners present FYB207 Results at International Keystone Symposium	Formycon AG
12-Jan-2021	MorphoSys and Incyte Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab	MorphoSys AG
12-Jan-2021	SANOFI unveils EUROAPI as the name of the new industry leading European API* company and appoints Karl Rotthier as its future Chief Executive Officer	Sanofi
12-Jan-2021	Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D	Boehringer Ingelheim
12-Jan-2021	Hansa Biopharma provides business update incl. certain key financials ahead of the JP Morgan Global Healthcare Conference	Hansa Biopharma
12-Jan-2021	Daridorexant new drug application (NDA) submitted to the US Food & Drug Administration (FDA) on January 8, 2021	Idorsia Ltd
12-Jan-2021	Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases	Chi-Med
12-Jan-2021	Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L	Sanofi